FDA Drug Recalls

Recalls / Class III

Class IIID-0219-2018

Product

Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30

Affected lot / code info
Lot#: 7H66200103G, Exp 12/19

Why it was recalled

Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules

Recalling firm

Firm
Shionogi Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
5770 Shiloh Rd, N/A, Alpharetta, Georgia 30005-8408

Distribution

Quantity
968 bottles
Distribution pattern
U.S.A. Nationwide

Timeline

Recall initiated
2017-05-24
FDA classified
2018-01-12
Posted by FDA
2018-01-24
Terminated
2018-02-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0219-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.